Antidepressants and Breast and Ovarian Cancer Risk: A Review of the Literature and Researchers' Financial Associations with Industry

BACKGROUND: Antidepressant (AD) use has been purported to increase the risk of breast and ovarian cancer, although both epidemiological and pre-clinical studies have reported mixed results [1]–[6]. Previous studies in a variety of biomedical fields have found that financial ties to drug companies ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Cosgrove, Lisa, Shi, Ling, Creasey, David E., Anaya-McKivergan, Maria, Myers, Jessica A., Huybrechts, Krista F.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071810/
https://www.ncbi.nlm.nih.gov/pubmed/21494667
http://dx.doi.org/10.1371/journal.pone.0018210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071810/
https://www.ncbi.nlm.nih.gov/pubmed/21494667
http://dx.doi.org/10.1371/journal.pone.0018210

Ejemplares similares